FDA Emergency Use Authorization for Paxlovid

The U.S. Food and Drug Administration (FDA) revised the Emergency Use Authorization (EUA) for Paxlovid to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients under certain conditions.

For more information and conditions that would not allow a pharmacist to prescribe Paxlovid, read the FDA's press release regarding the EUA here.

You can also find the press release, EUA letter of authorization, FDA's compilation of frequently asked questions on the EUA, and a fact sheet for healthcare providers via the buttons below.

FDA's Press Release

EUA Letter of Authorization

FAQs about the EUA

Fact Sheet for Healthcare Providers